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Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human
cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human
malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However,
the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in
six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry,
and expression of cell cycle proteins, p53, p21
WAF1/CIP1 and p27
KIP1. In addition, we studied p53 gene mutations and expression of
SV40 Tag. After exposure to g-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a
heterogeneity in cell cycle control. G1 arrest was p21
WAF1/CIP1- and p53-dependent. Lack of arrest in G1 was not related to p53
mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to
understand mesothelioma and develop new treatments.
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Malignant mesothelioma (MM) is an insidious tumour with a
dismal prognosis. Owing to past asbestos exposure and because of
the long latency period of the disease, mesothelioma mortality will
continue to increase over the next decades (Peto et al, 1999; Banaei
et al, 2000). Knowledge of biological features and specific
molecular targets of cancer cells may lead to advances in both
diagnosis and therapy (Karp and Broder, 1994; Blagosklonny and
Pardee, 2001). Cell cycle regulation is of particular interest in the
overall control of cancer cell survival. (Shah and Schwartz, 2001).
The protein p53 is an important cell cycle regulator that induces
expression of genes that halt the cell cycle and trigger cell death
(Agarwal et al, 1998; May and May, 1999). While p53 is mutated in
many types of tumours, mutations were found only in a limited
number of MM (Greenblat et al, 1994). On the other hand, in MM,
p53 may be inactivated via its association with the SV40 early
region T antigen (SV40 Tag) (Testa and Giordano, 2001). Thus,
strategies have been proposed recently to induce arrest of MM cell
proliferation and apoptosis by the restoration of p53 function. This
has been carried out following gene transfer, either by the
overexpression of p53 (Giuliano et al, 2000), by the expression
of regulators of p53 levels such as p14
ARF (Yang et al, 2000) or by
the expression of antisense transcripts to Tag (Waheed et al, 1999).
So far, however, a number of MM have not been found to express
SV40 Tag (Strickler et al, 1996). Also, these methods may not be
functional in cells that do not contain viral molecules, as quoted by
Waheed et al (1999). For strategies involving anticancer drugs, the
effect on cancer cells depends both on the nature of the drug and
on the molecular status of the cancer cells, particularly p53 activity
(Bunz et al, 1999). Thus, it would be important to determine
whether the function of p53 is inactivated in MM cells and to
investigate their response to p53 activating agents. Therefore, we
studied the activity of p53 in human MM cell lines (HMCLs) by
characterising the function of the G1/S and G2/M checkpoints in
six HMCLs exposed to g-radiation, and by the determination of
their associated p53 mutation status and Tag SV40 expression.
We found that all cell lines were responsive to irradiation, as
shown by cell cycle arrest, but two HMCLs failed to arrest in G1
phase of the cell cycle. No apoptosis was observed. Arrest in G1
was p21
WAF1/CIP1-dependent via p53. No SV40 Tag expression was
found, but one HMCL presented a missense mutation at codon
248. These results demonstrate that HMCLs appear to be resistant
to DNA-damaging agents and suggest that therapies combining
abrogation of cell cycle checkpoints and enhancement of the cell
death mechanisms should be investigated in MM.
MATERIALS AND METHODS
Human mesothelioma cell lines (HMCLs)
Human mesothelioma cell lines were obtained from confirmed
MM cases and were cultured as described elsewhere (Buard et al,
1998) in RPMI 1640 medium with L-glutamine supplemented with
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y8% fetal bovine serum, 10mmoll
 1 HEPES buffer (both from Life
Technologies, Inc., Cergy Pontoise, France), 50Uml
 1 penicillin
and 50mgml
 1 streptomycin (ATGC Biotechnologie, Noisy le
Grand, France).
Six HMCLs, RV, BT, BR, BL, CR and FR obtained from
mesothelioma cases were used in the present study. They were
used between passages 3 and 15. The mesothelial origin of the cells
was assessed by the coexpression of cytokeratin and vimentin and
absence of expression of carcinoembryonic antigen (Zeng et al,
1994). Moreover, an expression of calretinin was found in all
HMCLs using the rabbit polyclonal anticalretinin antibody
(Zymed) (unpublished data).
Treatment with c-radiation
Cells were plated on 75cm
2 flask (Costar, Dutscher, Brumath,
France) at 2 10
4 cells cm
 2. At 70% confluence, cells were washed
with phosphate-buffered saline (PBS) 1 , and flasks were filled to
the neck with serum-free RPMI 1640 culture medium. HMCLs were
irradiated at 6, 9 or 12Gy (1.2Gymin
 1) by exposure to a
60Co
source (Alcyon from General Electric Medical System, France).
After irradiation, the serum-free RPMI was replaced with complete
RPMI 1640 medium and the flasks were returned to 371C.
Cell cycle analysis by flow cytometry
After different durations of exposure to g-radiation, bromodeoxy-
uridine (BrdU) (Sigma, St Quentin-Fallavier, France; final con-
centration: 18mgml
 1) was added to the culture medium for 1h.
After incubation, the cells were treated as described elsewhere
(Vivo et al, 2001). Briefly, cells were trypsinised, washed in PBS,
fixed in 70% ethanol and resuspended in 2N HCl at room
temperature for 30min. After washing with 0.5% Tween 20 in
PBS (PBST), cells were centrifuged and rinsed until the pH settled
between 7.2 and 7.4, and incubated with BrdU antibodies diluted
1:10 in PBST (Dako, Trappes, France) at room temperature for
30min, followed by three washes with PBST. The pelleted cells
were then resuspended and incubated 30min at room temperature
in 100ml of anti-mouse IgG antibodies (Dako, Trappes, France)
conjugated with fluorescein isothiocyanate (FITC), diluted at 1:20
in PBST. After three washes, cells were stained with propidium
iodide (PI) (0.05mgml
 1 final concentration) for 1h at room
temperature in the dark. As a control for FITC specificity, the first
antibody was omitted from the incubation procedure in some
samples.
In total, 30000 HM cells were analysed per treatment with a flow
cytometer Coulter Epics XL WO5039 (Coultronics, Margency,
France). A dual parameter histogram of the cell cycle phase
distribution and calculations of the percentage of cells in G0/G1, S
and G2/M phases were obtained by analysis of each sample using
XL software. Distribution of cells in the different phases of the cell
cycle was also analysed by Multicycle software (Phoenix Flow
Systems, San Diego, CA, USA). Each experiment was performed in
triplicate. Data are presented as a representative sample.
PCR and RT–PCR analyses of SV40 Tag DNA sequences
Cell DNA was amplified using the primers PYV. for
(50-TAGGTGCCAACCTATGGAACAGA-30) and PYV. rev
(50-GGAAAGTCTTTAGGGTCTTCTACC-30) (Carbone et al,
1994). Polymerase chain reaction (PCR) was carried out with
Taq DNA polymerase (Invitrogen). Thermocyclin was performed
by denaturation at 941C for 3min, followed by cycling 35 times at
941C for 1min, at 55 for 1min, and at 721C for 1min. The products
were separated by electrophoresis. As positive control, SV40 Tag
transduced rat pleural mesothelial cells were used (Pilatte et al,
2000).
RNA was extracted from cell lines using the RNeasy Mini kit
(Qiagen). Total RNA (1.5mg) was reverse transcribed with oligodT
(Promega) using the Superscript II RT kit (Gibco BRL) following
the manufacturer’s recommendations. PCR was performed with
PYV.for and PYV.rev primers. A measure of 2ml of the cDNA
reaction product was amplified in 1  buffer, 0.2mM dNTPs,
1.5mM MgCl2, 0.25mM primers and 25mUml
 1 Taq DNA
polymerase (Invitrogen). After an initial denaturation at 941C for
2min, 35 cycles were performed consisting of denaturation at 941C
for 30s, annealing at 551C for 1min and extension at 721C for
1min. The final extension step was continued for 5min. PCR
product was analysed by electrophoresis on a 2% agarose gel
and ethidium bromide staining. GAPDH amplification (quantit-
ative control) was performed as described above with
GAPDH50 (50-GGATTTGGTCGTATTGGGCGC-30) and GAPDH30
(50-GTTCTCAGCCTTGACGGTGC-30) primers.
Protein analysis by Western blot
Total cell extracts To prepare extracts, the cell layer was washed
three times with 10ml PBS and scraped on ice after addition of a
lysis buffer (1mM EDTA, 5mM NaF, 1% NP40, 1mM sodium
orthovanadate, 1mgml
 1 leupeptine, 25mM NPGB and 5mM
sodium pyrophosphate in PBS). Cells were further lysed by
repeated passages through a 21-gauge needle, and lysates were
cleared by centrifugation at 16000g for 15min at 41C.
Nuclear and cytoplasmic protein extraction After washing in PBS,
cells were scraped on ice in a sucrose buffer (250mM sucrose, 3mM
imidazole and 1mM EDTA used as protease inhibitor) in PBS 1X,
lysed by repeated passages through a needle. After centrifugation
at 300g for 10min at 41C, the cytoplasmic protein concentration of
the supernatant was determined. The pellet (nuclei and unbroken
cells) was resuspended in sucrose buffer, homogenised with needle
as above and centrifuged at 300g for 10min. Both supernatants
(cytoplasmic fraction) were pooled and centrifuged at 100000g for
1h. The pellet was resuspended in lysis buffer (see above ‘Total cell
extracts’), homogenised with needle and centrifuged at 15000g for
15min at 41C. This supernatant contained the nuclear fraction.
Immunoprecipitation for SV40 Tag detection SV40 Tag detection
was performed as described elsewhere (Pilatte et al, 2000). Briefly,
MM cells were washed, scraped in lysis buffer (see above ‘Total cell
extracts’) and lysed by repeated passages through a needle. Lysates
were cleared by centrifugation at 16000g for 15min at 41C. After
preclearing with Protein A–Sepharose beads (Pharmacia Biotech,
Orsay, France), protein concentration was determined using the
DC Protein assay (Bio-Rad, Ivry sur Seine, France) and normalised
by addition of extraction buffer. The cell lysate was incubated with
anti-p53 antibody (D01, Santa Cruz, Biotechnology, Inc., Tebu,
France, Le Perray-en-Yvelines) for 2h at 41C( 3mg antibody: 1mg
total pro-tein). Immunocomplexes were collected on protein A–
Sepharose 1h at 41C, and washed four times with immunopreci-
pitation buffer (40mM HEPES, 8mM MgCl2, 100mM NaCl, 0.5%
Nonidet P-40, 2mgml
 1 aprotinin, 2mgml
 1 leupeptin, 100mM
Na3VO4). Immunocomplexes were resuspended in loading buffer
and analysed by Western blot using anti-SV40 Tag antibody (Pab
101, Santa Cruz). Positive control consisted in a cell extract from
SV40 Tag transduced rat pleural mesothelial cells (Pilatte et al,
2000).
Western blots The following antibodies were used: primary
mouse monoclonal antibodies against human p21
WAF1/CIP1,
p27
KIP1, p53 (D01) and SV40 Tag (Ab-1), all from Santa Cruz.
A total of 40mg of total protein extract was boiled for 5min in
SDS loading buffer with 1% b mercaptoethanol, and loaded onto
7.5–12% SDS-polyacrylamide gel(PAGE), depending on the
protein type. After electrophoresis, proteins were transferred to
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yan Immobilon-P membrane (Millipore, St Quentin en Yvelines,
France). The protein transfer was confirmed with a red Ponceau
staining and the membrane was blocked with 5% nonfat milk in
PBST for 1h at room temperature. Peroxidase-conjugated anti-
mouse IgG secondary antibody (Santa Cruz) was used at 1:2000
dilution in PBS containing 5% nonfat milk and 0.5% Tween 20 for
1h at room temperature and washed again for 30min in PBS.
Proteins were detected using the ECL method (Amersham, Life
Science, Les Ulis, France).
p53 mutation analysis
Amplification by PCR Genomic DNA was isolated from HMCLs
and normal lymphocytes by proteinase K digestion and phenol/
chloroform extraction. The DNA (100ng) was amplified (Perkin-
Elmer). Primers to amplified fragments of the p53 gene (Table 1)
from exons 2–9 were selected according to previous research in
the laboratory and primers for exons 10 and 11 were selected from
previously published information (Kazachkov et al, 1996).
Amplification of exons 2–9 was performed in two steps: first, a
multiplex PCR was used to amplify exons 2–9 in three parts
(exons 2–4; exons 5 and 6; exons 7–9) and second, a nested PCR
was used to amplify for each exon. Multiplex PCR cycle
amplification for exons 2–9 was 1 cycle for 5min, 921C; 30 cycles
for 90s, 921C; 105s, 581C; 150s, 721C and 1 cycle for 15min, 721C.
Nested PCR cycle amplification for exons 2–9 was 1 cycle for
5min, 921C; 30 cycles for 90s, 921C; 105s, 541C; 150s, 721C and 1
cycle for 15min, 721C. Exons 10 and 11 amplification was
performed directly in nested PCR. The amplification cycle for
exon 10 was 7min, 941C; 40 cycles, 1min, 951C; 1min, 581C; 1min,
721C and 7min, 721C. The amplification cycle for exon 11 was
7min, 941C; 35 cycles, 1min, 951C; 1min, 551C; 1min, 721C and
7min, 721C.
Single-strand conformation polymorphism (SSCP) SSCP analysis
was performed on each PCR product for exons 2–9. Each PCR
product was mixed with one volume of denaturating solution (95%
formamide, 20mM EDTA, 0.05% xylene cyanol, 0.05% bromophe-
nol blue), heated for 5min at 951C, cooled on ice and subjected to
nondenaturing electrophoresis in a 10% PAGE (Clean gel 48S kit,
Amersham Pharmacia Biotech, Sweden). The gels were electro-
phoresed for 1h at 200–600V at 151C for exons 2–8 and 41C for
exon 9. After migration, gels were treated with the Plusone kit for
silver DNA staining (Pharmacia Biotech) and dried.
DNA sequencing DNA sequencing was performed on any PCR
product that showed a conformational change in SSCP analysis
and on all the PCR products of exons 10 and 11. Nucleotide
sequences were determined by the Dye terminator method for
exon 4 (ABI PRISM Dye Terminator Cycle Sequencing Ready
Reaction Kit with AmpliTaq DNA Polymerase, FS, Perkin-Elmer)
and Dye Primer ready reaction mixes for exon 9. Fragments were
sequenced on both strands. Sequencing reactions were loaded on a
4.25% acrylamide–7 M urea denaturing gel using an ABI 377
(Applied Biosystems, Foster City, CA, USA) sequencing apparatus
and mutational analysis performed with ‘Sequence Navigator’
Software. PCR products of exons 10 and 11 were sequenced by
Eurogenteck (Belgium). Computer analysis of the mutations was
performed with ‘Sequence Navigator’ software.
RESULTS
Cell distribution in the different phases of the cell cycle
after exposure to c-radiation
Two cell lines, RV and BT, did not arrest in G1 phase (2C amount
of DNA), since a concurrent decrease of the percentage of cells in
G0/G1 phase was found, as well as a nearly unmodified BrdU
incorporation (Figure 1A). However, these two cell lines exhibited
an arrest in G2/M phase, as demonstrated by the marked increase
in the number of cells with a 4C DNA content on the PI profile. No
subG1 peak of apoptotic cells was observed. Histograms
(Figure 1B) show that the enhancement in the percentage of cells
arrested in the G2/M phase was dose-dependent.
In contrast, four HMCLs presented an arrest in G1 phase after
similar exposure but also with no apoptosis. G1 arrest is
demonstrated in the cell line BR, by an increase in the percentage
of cells present in the G0/G1 compartment and a decrease in cells
labelled with BrdU. Moreover, a decrease in the number of cells
Table 1 Sequences of P53 primers
Amplified
fragment
Nucleotide position in
genomic DNA
Fragment
size (bp) Primers
a
Exon 2 11 642–11 873 232 (1) CAGGGTTGGAAGCGTCTCATG
(2) AATTTTCGCTTCCCACAGG
Exon 3 11 832–11 951 120 (1) CAACCCCAGCCCCCTAGCAG
(2) TCCCAGCCCAACCCTTGTCC
Exon 4 11 925–12 416 492 (1) CTGGTAAGGACAAGGGTTGG
(2) ACACTGACAGGAAGCCTAAGGGT
Exon 5 12 969–13 328 360 (1) TTTGTTTCTTTGCTGCCGTGTT
(2) GGGCCAGACCTAAGAGCAATCA
Exon 6 13 246–13 564 319 (1) GCTGGGGCTGGAGAGACGACA
(2) ACTTTGCACATCTCATGGGGTT
Exon 7 13 943–14 378 436 (1) TGCCACAGGTCTCCCCAAGG
(2) GGCTCCATCTACTCCCAACCACC
Exon 8 14 373–14 616 244 (1) GGAGCCTGGTTTTTTAAATGGG
(2) TCCACCGCTTCTTGTCCTGCT
Exon 9 14 596–14 849 254 (1) AGCAGGACAAGAAGCGGTGGA
(2) GCCCCAATTGCAGGTAAAACA
Exon 10 17 543–17 735 193 (1) TTACTTCTCCCCCTCCTCTGTTG
(2) GCTTTCCAACCTAGGAAGGCAG
Exon 11 18 567–18 795 229 (1) TCATCTCTCCTCCCTGCTTCTGTC
(2) TGCTTCTGACGCACACCTATTG
a(1) sense primer; (2) antisense primer.
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yFigure 1 Flow cytometric analysis of HMCLs after exposure to g-radiation. (A) Left: nonirradiated cells; right: 24h after exposure to 6Gy. Double
labelling: PI (x-axis) and BrdU (y-axis). The different areas N, M and P represent cells in G0/G1, cycling S cells and cells in G2-M, respectively. (B) Dose-
dependent cell distribution in different phases of the cell cycle. Percentage of cells in G0/G1 (hatched bars), S (black bars), G2/M (grey bars), 24h after
exposure to 6, 9 and 12Gy.
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agreement with a lack of G2/M arrest in this cell line. The
histogram (Figure 1B) shows that these effects were dose-
dependent. Dot plot and histogram analyses of the other cell lines
(BL, CR and FR) suggested an arrest both in G0/G1 and G2/M
phases of the cell cycle after exposure to g-radiation. All three cell
lines exhibited a strong decrease in the number of cells
incorporating BrdU in response to g-radiation, in agreement with
a G1 arrest; this was associated with a net increase of the amount of
cells in the G2/M compartment in the CR and BR cell lines. In the
FR cell line, the arrest in G1/S is suggested by the lack of decrease
in the proportion of cells present in the G1 compartment, after
irradiation.
In order to determine the time-dependent response following
exposure to g-radiation and to confirm the double arrest in the
three cell lines BL, CR and FR, a kinetic study of the cell
distribution in the phases of the cell cycle was carried out after
exposure to 6Gy. Accordingly, the results show a time-dependent
decrease in the percentage of cells in S phase (Figure 2), associated
with an increase or a stabilisation in the percentage of cells in G1
and G2/M phases. Modifications of the cell distribution were
detectable from different time postirradiation depending on the
cell line.
p53 expression in HMCLs exposed to g-radiation HMCLs were
treated according to the same protocol as for the cell cycle studies.
Western blot analysis of cells exposed to different doses of
radiation showed no evident modification in the expression of p53
protein in the majority of HMCLs 24h after irradiation (Figure 3A).
However, at an earlier time point (0–6h after irradiation) an
enhancement of p53 protein expression was observed in cell lines
showing an arrest in G1 suggesting a transient stabilisation of p53
in these HMCLs (Figure 4).
Subcellular localisation of the p53 protein Since p53 is a
transcription factor, its subcellular localisation is of importance
to account for its activity. The intracellular localisation of p53 was
investigated in five HMCLs following exposure to 6Gy, after
concentration of nuclear proteins as described in Materials and
Methods. The results indicate that p53 was present in the nuclear
fraction of all HMCLs both in the absence of treatment and after
irradiation (data not shown).
Effect of exposure to g-radiation on p21
WAF1/CIP1 and p27
KIP1
expression in HMCLs In the HMCLs failing to arrest at the G1/S
transition, no induction of p21
WAF1/CIP1 was found; instead,
p21
WAF1/CIP1 protein decreased in RV and p21
WAF1/CIP1 was
undetectable in BT (Figure 3B). In contrast, in cells with a G1
arrest, p21
WAF1/CIP1 expression was enhanced at different times
postirradiation. After 24h, a clear induction was observed in BR,
BL and CR at all experimental doses and moderately in FR
(Figure 3B). However, at earlier time points, 1.5 and 3h, an
induction was found in CR and FR cell lines (Figure 4).
After irradiation, p27
KIP1 expression was constant in HMCLs
exhibiting a double arrest in G1 and G2/M phases (BL, CR and FR).
p27
KIP1 protein expression was markedly lowered in a dose-
dependent manner in the HMCLs that did not arrest in G1 (RV and
BT) (data not shown). In contrast, a dose-dependent enhancement
in p27
KIP1 was found in BR, a cell line that exhibited a G1 blockade
not associated with a G2/M arrest.
SV40 Tag DNA and RNA sequence detection and protein
expression SV40 Tag DNA and RNA sequences were not detected
by PCR except in the positive control (Figure 5). By Western blot
analysis, neither the HMCLs investigated here nor the HL60 line
(negative control) exhibited a band corresponding to SV40 Tag,
whereas the positive control presented the expected band at 94kDa
(Figure 6).
Investigation of P53 mutation Results showed that one cell line
(BT) exhibited a P53 gene mutation. This mutation is a transition
affecting codon 248 (CGG-CAG) converting an arginine into
glutamine associated with a loss of the wild-type allele (Figure 7).
DISCUSSION
In this study, we investigated cell cyle control in HMCLs exposed
to g-radiation by flow cytometry, and characterised their p53 status
through analysis of p53 mutation status and Tag SV40 expression.
Our results demonstrate that four of six HMCLs responded to g-
irradiation by cell cycle arrest in G1 phase. The two HMCLs that
failed to arrest in G1 were arrested in G2/M. G1 arrest in HMCLs
appears to be p53- and p21
WAF1/CIP1-dependent, as shown by the
dose-dependent enhancement of p21
WAF1/CIP1 expression in the
G1-arrested cell lines. These results agree with cited experiments
demonstrating that p21
WAF1/CIP1 is necessary for p53-mediated G1
arrest in human colon carcinoma cells generated by DNA-
damaging agents (Waldman et al, 1995). Interestingly, the
strongest enhancement of p21
WAF1/CIP1 was found in an HMCL
that arrested only in G1 (BR). In contrast, two HMCLs that did not
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Figure 2 Kinetics of the distribution of mesothelioma cells (BL, CR and
FR HMCLs) in the different phases of the cell cycle: G0/G1 (hatched bars),
S (black bars), G2/M (grey bars), at different times after irradiation (6Gy).
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WAF1/CIP1 expres-
sion did not arrest in G1.
The inhibitor of the cyclin E- (cyclin-dependent kinase) (CDK2)
p27
KIP1, of which accumulation is observed in response to
antiproliferative signals, does not appear to be involved in the
response of MM cells to g-radiation. An enhancement of p27
KIP1
protein expression was found only in the BR cell line that arrested
in G1 (data not shown). This result agrees with the literature
findings showing that p27
KIP1 degradation, because of the
phosphorylation and ubiquitination of the protein, occurs in cells
that are not in G1 phase (Desdouets et al, 2000).
Our results show that all but one HMCL presented a wild-type
P53 gene. A missense mutation at codon 248 was observed in the
BT cell line. We believe that this is the first report of such a point
mutation in a characterised human mesothelioma cell line. This
cell line was obtained from a confirmed human mesothelioma case
and exhibited both the ultrastructural features and immunocyto-
chemical characteristics of mesothelial cells based on coexpression
of cytokeratin and vimentin, and absence of carcinoembryonic
antigen expression (Zeng et al, 1994; Fleury-Feith et al, 1995).
More recent markers, calretinin and CAK1 were also expressed in
this cell line. In the literature, this mutation was also reported in a
‘NOS’ (not otherwise specified) mesothelioma cell line (Olivier
et al, 2002).
It is generally accepted that p53 is required for the G1 arrest of
mammalian cells after exposure to g-radiation. We found that p53
was active in four cell lines, but failed to control cell cycle in two
HMCLs. p53 is likely to be inactivated by mutation in BT, but no
mutation was found in RV. In this cell line, p53 does not appear to
be inactivated by Tag SV40, since we were unable to detect Tag
SV40 DNA or RNA sequences nor to immunoprecipitate Tag SV40
in the HMCLs investigated here, even though the protein was
detected in positive control cells. This is consistent with results
reported in other HMCLs (Pilatte et al, 2000).
Basal expression of p53 was found in the HMCLs investigated
here. Similar findings have been reported in other cancer cell lines
(Nagasawa et al, 1998; Ashcroft et al, 2000). Interestingly,
both wild-type p53 and mutant p53
248 were present in the
nucleus as well as in the cytoplasm as determined by Western
blotting, but only the mutant protein was detected by immuno-
cytochemistry using antibodies recognising both forms of p53
(data not shown). This suggests strong stabilisation of the mutant
p53
248 in these cells. p53 WT stabilisation in HMCLs is likely
associated with deregulation of p53 expression. This may be
because of several mechanisms including alteration of mdm2
activity (Blattner et al, 2002) and/or of ARF expression (Oren et al,
2002). The mechanism by which WT p53 is stabilised in human
mesothelioma cells remains to be discovered, but it may be
suggested that deregulation of expression is a parameter to
consider in the mechanism of mesothelial cell transformation.
Alternatively, other tumor suppressor genes P16/CDKN2A and NF2
have been found to play a role in mesothelial oncogenesis (Murthy
and Testa, 1999).
Most mammalian cells arrest in G1 and G2 phases of the cell
cycle after exposure to g-radiation (Hartwell et al, 1994). The role
of p53 in G2 arrest is more controversial, likely depending on the
type of cell and its biological status. p53 appears to be involved in
G2 arrest duration (Bunz et al, 1998). Arrest in G2 after DNA
damage occurs in the absence of p21
WAF1/CIP1 and p53 (Waldman
et al, 1995). Abrogation of p53 by E6 transfection results in loss of
G1 control, but not G2 in human colon carcinoma cells (Wouters
et al, 1999). Our results are consistent with these observations
since HMCLs defective in p53 either by mutation (BT) or by failure
of p21
WAF1/CIP1 induction (RV) arrested in the G2/M phase. The
present data suggest that the G2 control checkpoint induced by
DNA damage is functional in most HMCLs.
In the present experiments, p53 does not appear to trigger
apoptosis following g-radiation of HMCLs. From another source,
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Figure 3 p53 (A) and p21
WAF1/CIP1 (B) protein expression in HMCLs after exposure to several doses of g-radiation. At 24h after irradiation, protein
extracts were subjected to SDS-PAGE electrophoresis followed by immunoblot analysis with antibodies against the corresponding antigens. ECL detection.
Densitometric analyses of p53 and p21
WAF1/CIP1 expression are reported on the top of the corresponding bands as percentage of the amount of protein
expressed in untreated cells.
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p53 by transfection with an adenovirus carrying human p14(ARF)
cDNA has been found to reduce cell proliferation and enhance
apoptosis (Yang et al, 2000). Lack of apoptosis in cells with
functional p53 may result from regulation by antiapoptotic signals
that control cell survival. The role of these factors in the response
to drug combination merits further investigation. In the same vein,
recent reports show significant augmentation of proapoptotic gene
therapy by pharmacological downregulation of survival signals in
MM cells (Cao et al, 2001; Mohiuddin et al, 2001). Furthermore, both
tumour necrosis factor-related apoptosis-inducing ligand and che-
motherapy cooperate to induce apoptosis in HMCLs (Liu et al, 2001).
In conclusion, HMCLs exhibited different responses to g-
radiation exposure. However, all cell lines showed activation of
the cell cycle control checkpoints after irradiation in either one or
in both phases of the cell cycle. The protein p53 may exert a
control of cell proliferation in several cell lines, but some failed to
activate the p53 function. Our results confirm previous findings of
a low mutation rate of p53 in MM and suggest that understanding
the details of G1/S and G2/M control checkpoints in mesothelioma
cell lines may prove critical to the development of potential novel
therapeutic strategies, especially based on the triggering of
apoptosis.
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Figure 4 Kinetics of p53 and p21
WAF1/CIP1 expression in HMCLs (BL,
CR and FR) showing an arrest at the G1/S transition in response to g-
radiation. Cells were exposed to 6Gy as described in Materials and
Methods and protein extracts were analysed at the indicated times
postirradiation. Densitometric analyses are expressed as in Figure 3.
Figure 5 PCR (A) and RT–PCR (B) analyses of DNA and RNA
extracted from HMCLs as described in Materials and Methods. Amplifica-
tions were carried out with PYV.for and PYV.rev for SV40 Tag primers.
Positive control was SV40 Tag transduced rat pleural mesothelial cells
(SV40). ( ): negative control. GAPDH amplification (165bp) was used as
quantitative RT–PCR control.
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Figure 6 Western blot analysis of SV40 Tag. Cell extracts were
immunoprecipitated with an anti-p53 antibody and the resulting immuno-
precipitates were immunobloted with anti-Tag antibody as described in
Materials and Methods. None of the six HMCLs investigated here and
HL60 (negative control) presented a band corresponding to SV40 Tag,
whereas the positive control (SV40) showed the expected band at 94kDa.
Figure 7 Electrophoregram of P53 gene part of exon 7: (A1) coding
strand of CR cell line; (A2) noncoding strand of CR cell line. (B1) coding
strand of BT cell line; (B2) coding strand of BT-cell line.
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